Literature DB >> 28930616

Development of a semi-automated image-based high-throughput drug screening system.

Remzi Onur Eren1, Dmitry Kopelyanskiy1, Dimitri Moreau2, Julien Bortoli Chapalay3, Marc Chambon3, Gerardo Turcatti3, Lon-Fye Lye4, Stephen M Beverley4, Nicolas Fasel5.   

Abstract

We previously reported that the innate sensing of the endosymbiont Leishmania RNA virus 1 (LRV1) within Leishmania (Viannia) guyanensis through Toll-like receptor 3, worsens the pathogenesis of parasite infection in mice. The presence of LRV1 has been associated with the failure of first-line treatment in patients infected with LRV1 containing -L. guyanensis and -L. braziliensis parasites. Here, we established a semi-automated image-based high-throughput drug screening (HTDS) protocol to measure parasiticidal activity of the Prestwick chemical library in primary murine macrophages infected with LRV1-containing L. guyanensis. The two-independent screens generated 14 hit compounds with over sixty-nine percent reduction in parasite growth compared to control, at a single dose in both screens. Our screening strategy offers great potential in the search for new drugs and accelerates the discovery rate in the field of drug repurposing against Leishmania. Moreover, this technique allows the concomitant assessment of the effect of drug toxicity on host cell number.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28930616      PMCID: PMC5735416          DOI: 10.2741/e820

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  35 in total

1.  Antimycin A resistance in a mutant Leishmania tarentolae strain is correlated to a point mutation in the mitochondrial apocytochrome b gene.

Authors:  A Schnaufer; S Sbicego; B Blum
Journal:  Curr Genet       Date:  2000-04       Impact factor: 3.886

2.  Cu/Zn superoxide dismutase plays important role in immune response.

Authors:  Moshe Marikovsky; Vered Ziv; Nava Nevo; Catherine Harris-Cerruti; Ori Mahler
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

3.  In vitro and experimental therapeutic studies of the calcium channel blocker bepridil: detection of viable Leishmania (L.) chagasi by real-time PCR.

Authors:  Juliana Q Reimão; Fábio A Colombo; Vera L Pereira-Chioccola; André G Tempone
Journal:  Exp Parasitol       Date:  2011-02-24       Impact factor: 2.011

4.  Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis.

Authors:  Annette Ives; Catherine Ronet; Florence Prevel; Giulia Ruzzante; Silvia Fuertes-Marraco; Frederic Schutz; Haroun Zangger; Melanie Revaz-Breton; Lon-Fye Lye; Suzanne M Hickerson; Stephen M Beverley; Hans Acha-Orbea; Pascal Launois; Nicolas Fasel; Slavica Masina
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

Review 5.  Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis.

Authors:  Thomas P C Dorlo; Manica Balasegaram; Jos H Beijnen; Peter J de Vries
Journal:  J Antimicrob Chemother       Date:  2012-07-24       Impact factor: 5.790

6.  Tetraethylthiuram disulfide (Antabuse) inhibits the human malaria parasite Plasmodium falciparum.

Authors:  L W Scheibel; A Adler; W Trager
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

7.  In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences.

Authors:  Marieke Vermeersch; Raquel Inocêncio da Luz; Kim Toté; Jean-Pierre Timmermans; Paul Cos; Louis Maes
Journal:  Antimicrob Agents Chemother       Date:  2009-06-22       Impact factor: 5.191

8.  Comparison of a high-throughput high-content intracellular Leishmania donovani assay with an axenic amastigote assay.

Authors:  Manu De Rycker; Irene Hallyburton; John Thomas; Lorna Campbell; Susan Wyllie; Dhananjay Joshi; Scott Cameron; Ian H Gilbert; Paul G Wyatt; Julie A Frearson; Alan H Fairlamb; David W Gray
Journal:  Antimicrob Agents Chemother       Date:  2013-04-09       Impact factor: 5.191

9.  Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning.

Authors:  Marcel Kaiser; Pascal Mäser; Leela Pavan Tadoori; Jean-Robert Ioset; Reto Brun
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

10.  Leishmaniavirus-Dependent Metastatic Leishmaniasis Is Prevented by Blocking IL-17A.

Authors:  Mary-Anne Hartley; Eliane Bourreau; Matteo Rossi; Patrik Castiglioni; Remzi Onur Eren; Florence Prevel; Pierre Couppié; Suzanne M Hickerson; Pascal Launois; Stephen M Beverley; Catherine Ronet; Nicolas Fasel
Journal:  PLoS Pathog       Date:  2016-09-22       Impact factor: 6.823

View more
  3 in total

1.  Past and future of trypanosomatids high-throughput phenotypic screening.

Authors:  Rafael Ferreira Dantas; Eduardo Caio Torres-Santos; Floriano Paes Silva
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-03-11       Impact factor: 2.743

2.  Leishmania guyanensis suppressed inducible nitric oxide synthase provoked by its viral endosymbiont.

Authors:  Dmitry Kopelyanskiy; Chantal Desponds; Florence Prevel; Matteo Rossi; Romain Migliorini; Tiia Snäkä; Remzi Onur Eren; Stéphanie Claudinot; Lon-Fye Lye; Manolis Pasparakis; Stephen M Beverley; Nicolas Fasel
Journal:  Front Cell Infect Microbiol       Date:  2022-08-12       Impact factor: 6.073

3.  Development of an automated image analysis protocol for quantification of intracellular forms of Leishmania spp.

Authors:  Ana G Gomes-Alves; André F Maia; Tânia Cruz; Helena Castro; Ana M Tomás
Journal:  PLoS One       Date:  2018-08-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.